Drugplain

Quality Choice Effervescent Cold Relief Plus 325 mg/1

Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate · TABLET, EFFERVESCENT · Chain Drug Marketing Association

No Recall History
Plain English

Quality Choice Effervescent Cold Relief Plus is a tablet, effervescent containing aspirin, chlorpheniramine maleate, and phenylephrine bitartrate at 325 mg/1, taken oral. Manufactured by Chain Drug Marketing Association.

Key Facts

Brand Name
Quality Choice Effervescent Cold Relief Plus
Generic Name
Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate
NDC Code (Product)
63868-228
Manufacturer
Chain Drug Marketing Association
Strength
325 mg/1
Dosage Form
TABLET, EFFERVESCENT
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]
Marketing Start
01/01/2014

Recall History

No Recall History

Frequently Asked Questions

What is Quality Choice Effervescent Cold Relief Plus used for?

Quality Choice Effervescent Cold Relief Plus contains Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate. It is a tablet, effervescent taken oral. Consult your doctor for specific uses.

Is Quality Choice Effervescent Cold Relief Plus a controlled substance?

Quality Choice Effervescent Cold Relief Plus is not classified as a controlled substance by the DEA.

What is the generic name for Quality Choice Effervescent Cold Relief Plus?

The generic name for Quality Choice Effervescent Cold Relief Plus is Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate. There are 2 other brand versions of Aspirin, Chlorpheniramine maleate, and Phenylephrine bitartrate.

What is the NDC code for Quality Choice Effervescent Cold Relief Plus 325 mg/1?

The NDC (National Drug Code) for Quality Choice Effervescent Cold Relief Plus 325 mg/1 is 63868-228, listed by Chain Drug Marketing Association.

Product NDC

63868-228

Package NDC

63868-228-20

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)